Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

A Randomized Clinical Trial of Liberal Versus Restrictive Transfusion Strategy Evaluating Long Term Survival and Cause of Death: Results from the FOCUS Trial

Jeffrey L. Carson, MD, Frederick Sieber, MD, Donald R Hoover, PhD MPH, Helaine Noveck, MPH, Bernard R Chaitman, MD, Lauren Beaupre, PT, PhD, William Macaulay, MD, George Rhoads, MD MPH, Lee Fleisher, MD, Donald Richard Cook, MD, David Sanders, MD, Khwaja Zakriya, MD, Barbara Paris, MD, Aleksandra Zagorin, DNP, MA, AGPCNP-BC, RN, Jay Magaziner, PhD

Blood (2014) 124 (21): 757.

https://doi.org/10.1182/blood.V124.21.757.757

Published: 2014

Journal Articles

Synergistic Activity of the Aurora Kinase Inhibitor MK-0457 (VX-680) with Idarubicin, Ara-C, and Inhibitors of BCR-ABL.

Russell R. Hoover, PhD, Matthew W. Harding, PhD

Blood (2006) 108 (11): 1384.

https://doi.org/10.1182/blood.V108.11.1384.1384

Published: 2006

Journal Articles

Overcoming STI571 resistance with the farnesyl transferase inhibitor SCH66336

Russell R. Hoover, Francois-Xavier Mahon, Junia V. Melo, George Q. Daley

Blood (2002) 100 (3): 1068–1071.

https://doi.org/10.1182/blood.V100.3.1068

Published: 2002

Journal Articles

Activity of the farnesyl protein transferase inhibitor SCH66336 against BCR/ABL-induced murine leukemia and primary cells from patients with chronic myeloid leukemia

David G. Peters, Russell R. Hoover, Melissa J. Gerlach, Eugene Y. Koh, Haiyan Zhang, Kevin Choe, Paul Kirschmeier, W. Robert Bishop, George Q. Daley

Blood (2001) 97 (5): 1404–1412.

https://doi.org/10.1182/blood.V97.5.1404

Published: 2001

Journal Articles

Adhesion of normal and sickle erythrocytes to endothelial monolayer cultures

R Hoover, R Rubin, G Wise, R Warren

Blood (1979) 54 (4): 872–876.

https://doi.org/10.1182/blood.V54.4.872.872

Published: 1979

NARROW

A Randomized Clinical Trial of Liberal Versus Restrictive Transfusion Strategy Evaluating Long Term Survival and Cause of Death: Results from the FOCUS Trial

Synergistic Activity of the Aurora Kinase Inhibitor MK-0457 (VX-680) with Idarubicin, Ara-C, and Inhibitors of BCR-ABL.

Overcoming STI571 resistance with the farnesyl transferase inhibitor SCH66336

Activity of the farnesyl protein transferase inhibitor SCH66336 against BCR/ABL-induced murine leukemia and primary cells from patients with chronic myeloid leukemia

Adhesion of normal and sickle erythrocytes to endothelial monolayer cultures

Email alerts

ASH Publications

American Society of Hematology

A Randomized Clinical Trial of Liberal Versus Restrictive Transfusion Strategy Evaluating Long Term Survival and Cause of Death: Results from the FOCUS Trial

Synergistic Activity of the Aurora Kinase Inhibitor MK-0457 (VX-680) with Idarubicin, Ara-C, and Inhibitors of BCR-ABL.

Overcoming STI571 resistance with the farnesyl transferase inhibitor SCH66336

Activity of the farnesyl protein transferase inhibitor SCH66336 against BCR/ABL-induced murine leukemia and primary cells from patients with chronic myeloid leukemia

Adhesion of normal and sickle erythrocytes to endothelial monolayer cultures

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only